Digitalis Lutea 100705

''Digitalis'' ( or ) is a genus of about 20 species of herbaceous perennial plants, shrubs, and biennials, commonly called foxgloves.

''Digitalis'' is native to Europe, western Asia, and northwestern Africa. The flowers are tubular in shape, produced on a tall spike, and vary in colour with species, from purple to pink, white, and yellow. The scientific name means "finger". The genus was traditionally placed in the figwort family, Scrophulariaceae, but phylogenetic research led taxonomists to move it to the Veronicaceae in 2001. More recent phylogenetic work has placed it in the much enlarged family Plantaginaceae.

The best-known species is the common foxglove, ''Digitalis purpurea''. This biennial is often grown as an ornamental plant due to its vivid flowers which range in colour from various purple tints through pink and purely white. The flowers can also possess various marks and spottings. Other garden-worthy species include ''D. ferruginea'', ''D. grandiflora'', ''D. lutea'', and ''D. parviflora''.

The term ''digitalis'' is also used for drug preparations that contain cardiac glycosides, particularly one called digoxin, extracted from various plants of this genus. Foxglove has medicinal uses but is also very toxic to humans and other animals, and consumption can even lead to death.

Etymology

The generic epithet ''Digitalis'' is from the Latin ''digitus'' (finger). Leonhart Fuchs first invented the name for this plant in his 1542 book ''De historia stirpium commentarii insignes'', based upon the German vernacular name ''Fingerhut'', which translates literally as 'finger hat', but actually means 'thimble'.

The name is recorded in Old English as 'foxes glofe/glofa' or 'fox's glove'. Over time, folk myths obscured the literal origins of the name, insinuating that foxes wore the flowers on their paws to silence their movements as they stealthily hunted their prey. The woody hillsides where the foxes made their dens were often covered with the toxic flowers. Some of the more menacing names, such as "witch's glove", reference the toxicity of the plant.

Henry Fox Talbot (1847) proposed 'folks' glove', where 'folk' means fairy. Similarly, R. C. A. Prior (1863) suggested an etymology of 'foxes-glew', meaning 'fairy music'. However, neither of these suggestions account for the Old English form ''foxes glofa''.

Taxonomy

Species

The ''Flora Europaea'' originally recognised a number of species now seen as synonyms of ''Digitalis purpurea'', or others: ''D. dubia'', ''D. leucophaea'', ''D. micrantha'' and ''D. trojana''. As of 2017, ''Plants of the World Online'' recognises the following 27 species (and a number of hybrids):
*'' Digitalis atlantica'' Pomel
*'' Digitalis canariensis'' L.
*'' Digitalis cariensis'' Boiss. ex Jaub. & Spach
*'' Digitalis cedretorum'' (Emb.) Maire
*'' Digitalis chalcantha'' (Svent. & O'Shan.) Albach, Bräuchler & Heubl
*'' Digitalis ciliata'' Trautv.
*''Digitalis davisiana'' Heywood
*'' Digitalis ferruginea'' L.
*'' Digitalis fuscescens'' Waldst. & Kit.
*''Digitalis grandiflora'' Mill.
*'' Digitalis ikarica'' (P.H.Davis) Strid
*'' Digitalis isabelliana'' (Webb) Linding.
*'' Digitalis laevigata'' Waldst. & Kit.
*''Digitalis lamarckii'' Ivanina
*''Digitalis lanata'' Ehrh.
*'' Digitalis lutea'' L.
*''Digitalis mariana'' Boiss.
*'' Digitalis minor'' L.
*'' Digitalis nervosa'' Steud. & Hochst. ex Benth.
*'' Digitalis obscura'' L.
*'' Digitalis parviflora'' Jacq.
*''Digitalis purpurea'' L.
*'' Digitalis sceptrum'' L.f.
*'' Digitalis subalpina'' Braun-Blanq.
*'' Digitalis thapsi'' L.
*'' Digitalis transiens'' Maire
*'' Digitalis viridiflora'' Lindl.

Hybrids

*'' Digitalis × coutinhoi'' Samp.
*''Digitalis × fulva'' Lindl.
*'' Digitalis × macedonica'' Heywood
*'' Digitalis × media'' Roth
*'' Digitalis × pelia'' Zerbst & Bocquet
*'' Digitalis × purpurascens'' Roth
*''Digitalis'' × ''sibirica'' (Lindley) Werner had been considered a valid species since it was first described by the English botanist and gardener John Lindley in 1821, but it was considered a hybrid of ''D. grandiflora'' and ''D. laevigata'' by the German botanist in 1960.

Systematics

The first full monograph regarding this genus was written by Lindley in 1821. He included two sections, a section ''Isoplexis'' including two species, and the main section ''Digitalis'' with three subsections, including 2Y species, a number of which are now seen as synonyms or hybrids.

In the last full monograph of the genus in 1965, Werner classified the 19 recognised species in five sections (four species from Macaronesia were separated in the genus ''Isoplexis'' at the time):
*In the section ''Digitalis'', along with the type species ''D. purpurea'', four other species (as recognised as the time) were placed: ''D. thapsi'', ''D. dubia'', ''D. heywoodii'' and ''D. mariana''.
*The monotypic section ''Frutescentes'' contained only ''D. obscura''.
*The section ''Grandiflorae'', which was also called section ''Macranthae'' by Vernon Hilton Heywood. It included, along with the type species ''D. grandiflora'', also ''D. atlantica'', ''D. ciliata'' and ''D. davisiana''.
*''Globiflorae'' included five species: ''D. laevigata'', ''D. nervosa'', ''D. ferruginea'', ''D. cariensis'' and ''D. lanata''.
*''Tubiflorae'' included four species: ''D. subalpina'', ''D. lutea'', ''D. viridiflora'' and ''D. parviflora''.

In their 2000 book about ''Digitalis'', Luckner and Wichtl continued to uphold Werner's classification of the 19 species, but molecular studies into the phylogeny of the genus published in 2004 found that although four of Werner's sections were supported by the genetics, the section ''Tubiflorae'' was polyphyletic, and that the species ''D. lutea'' and ''D. viridiflora'' should be placed in the section ''Grandiflorae''. This study, as well as a number of other studies published around that time, reunited the genus ''Isoplexis'' with ''Digitalis'', increasing the number of species to 23.

Peter Hadland Davis, an expert on the flora of Turkey, had used a different circumscription than Werner in his works, and recognised eight species in the country. A 2016 molecular phylogenetic study into the relationships of the Turkish species in the section ''Globiflorae'' aimed to reconcile this discrepancy, finding that the classification as proposed by Davis was largely correct: ''Globiflorae'' contained as distinct species ''D. cariensis'', ''D. ferruginea'', ''D. lamarckii'', ''D. lanata'' and ''D. nervosa'', and ''D. trojana'' was subsumed at the infraspecific rank as ''D. lanata'' subsp. ''trojana''. This study listed 23 species: ''D. transiens'', ''D. cedretorum'', ''D. ikarica'' and ''D. fuscescens'' were not mentioned. ''D. parviflora'' and ''D. subalpina'' were not tested in this study, but the 2004 study found these two species situated within the section ''Globiflorae''.

Ecology

Larvae of the foxglove pug, a moth, consume the flowers of the common foxglove for food. Other species of Lepidoptera eat the leaves, including the lesser yellow underwing.

Uses

Cardiac

Digitalis is an example of a drug derived from a plant that was formerly used by herbalists; herbalists have largely abandoned its use because of its narrow therapeutic index and the difficulty of determining the amount of active drug in herbal preparations. Once the usefulness of digitalis in regulating the human pulse was understood, it was employed for a variety of purposes, including the treatment of epilepsy and other seizure disorders, which are now considered to be inappropriate treatments.

A group of medicines extracted from foxglove plants are called digitalin. The use of '' D. purpurea'' extract containing cardiac glycosides for the treatment of heart conditions was first described in the English-speaking medical literature by William Withering, in 1785, which is considered the beginning of modern therapeutics. In contemporary medicine digitalis (usually digoxin) is obtained from ''D. lanata''. It is used to increase cardiac contractility (it is a positive inotrope) and as an antiarrhythmic agent to control the heart rate, particularly in the irregular (and often fast) atrial fibrillation. Digitalis is hence often prescribed for patients in atrial fibrillation, especially if they have been diagnosed with congestive heart failure. Digoxin was approved for heart failure in 1998 under current regulations by the Food and Drug Administration on the basis of prospective, randomized study and clinical trials. It was also approved for the control of ventricular response rate for patients with atrial fibrillation. American College of Cardiology/American Heart Association guidelines recommend digoxin for symptomatic chronic heart failure for patients with reduced systolic function, preservation of systolic function, and/or rate control for atrial fibrillation with a rapid ventricular response. Heart Failure Society of America guidelines for heart failure provide similar recommendations. Despite its relatively recent approval by the Food and Drug Administration and the guideline recommendations, the therapeutic use of digoxin is declining in patients with heart failure—likely the result of several factors. The main factor is the more recent introduction of several drugs shown in randomised controlled studies to improve outcomes in heart failure. Safety concerns regarding a proposed link between digoxin therapy and increased mortality seen in observational studies may have contributed to the decline in therapeutic use of digoxin, however a systematic review of 75 studies including four million patient years of patient follow-up showed that in properly designed randomised controlled studies, mortality was no higher in patients given digoxin than in those given placebo.

Variations

A group of pharmacologically active compounds are extracted mostly from the leaves of the second year's growth, and in pure form are referred to by common chemical names, such as digitoxin or digoxin, or by brand names such as Crystodigin and Lanoxin, respectively. The two drugs differ in that digoxin has an additional hydroxyl group at the C-3 position on the B-ring (adjacent to the pentane). This results in digoxin having a half-life of about one day (and increasing with impaired kidney function), whereas digitoxin's is about 7 days and not affected by kidney function. Both molecules include a lactone and a triple-repeating sugar called a glycoside.

Mechanism of action

Digitalis works by inhibiting sodium-potassium ATPase. This results in an increased intracellular concentration of sodium ions and thus a decreased concentration gradient across the cell membrane. This increase in intracellular sodium causes the Na/Ca exchanger to reverse potential, i.e., transition from pumping sodium into the cell in exchange for pumping calcium out of the cell, to pumping sodium out of the cell in exchange for pumping calcium into the cell. This leads to an increase in cytoplasmic calcium concentration, which improves cardiac contractility. Under normal physiological conditions, the cytoplasmic calcium used in cardiac contractions originates from the sarcoplasmic reticulum, an intracellular organelle that stores calcium. Human newborns, some animals, and patients with chronic heart failure lack well developed and fully functioning sarcoplasmic reticula and must rely on the Na/Ca exchanger to provide all or a majority of the cytoplasmic calcium required for cardiac contraction. For this to occur, cytoplasmic sodium must exceed its typical concentration to favour a reversal in potential, which naturally occurs in human newborns and some animals primarily through an elevated heart rate; in patients with chronic heart failure it occurs through the administration of digitalis. As a result of increased contractility, stroke volume is increased. Ultimately, digitalis increases cardiac output (cardiac output = stroke volume x heart rate). This is the mechanism that makes this drug a popular treatment for congestive heart failure, which is characterized by low cardiac output.

Digitalis also has a vagal effect on the parasympathetic nervous system, and as such is used in re-entrant cardiac arrhythmias and to slow the ventricular rate during atrial fibrillation. The dependence on the vagal effect means digitalis is not effective when a patient has a high sympathetic nervous system drive, which is the case with acutely ill persons, and also during exercise.

Digoxigenin

Digoxigenin (DIG) is a steroid found in the flowers and leaves of ''Digitalis'' species, and is extracted from ''D. lanata''. Digoxigenin can be used as a molecular probe to detect mRNA in situ and label DNA, RNA, and oligonucleotides. It can easily be attached to nucleotides such as uridine by chemical modifications. DIG molecules are often linked to nucleotides; DIG-labelled uridine can then be incorporated into RNA via ''in vitro'' transcription. Once hybridisation occurs, RNA with the incorporated DIG-U can be detected with anti-DIG antibodies conjugated to alkaline phosphatase. To reveal the hybridised transcripts, a chromogen can be used which reacts with the alkaline phosphatase to produce a coloured precipitate.

Toxicity

Depending on the species, the digitalis plant may contain several deadly physiological and chemically related cardiac and steroidal glycosides. Thus, the digitalis plants have earned several, more sinister, names: dead man's bells and witch's gloves.

Digitalis intoxication, known as ''digitalism'', results from an overdose of digitalis and causes gastrointestinal disturbances and pain, severe headache, nausea, vomiting and diarrhoea, cardiac arrhythmias, as well as sometimes resulting in xanthopsia (jaundiced or yellow vision). The toxins can be absorbed via the skin or ingestion; early symptoms of digitalism include nausea, vomiting, diarrhoea, abdominal pain, wild hallucinations, delirium, and severe headache. Depending on the severity of the toxicosis, the victim may later suffer irregular and slow pulse, tremors, various cerebral disturbances, especially of a visual nature (unusual colour visions (see xanthopsia) with objects appearing yellowish to green, and blue halos around lights), convulsions, and deadly disturbances of the heart. Other oculotoxic effects of digitalis include generalized blurry vision, as well as the appearance of blurred outlines ('halos'). Other things mentioned are dilated pupils, drooling, weakness, collapse, seizures, and even death. Because a frequent side effect of digitalis is reduction of appetite, some individuals have used the drug as a weight-loss aid.

Digitalis poisoning can cause heart block and either bradycardia (decreased heart rate) or tachycardia (increased heart rate), depending on the dose and the condition of one's heart. The electric cardioversion (to "shock" the heart) is generally not indicated in ventricular fibrillation in digitalis toxicity, as it can increase the dysrhythmia. Furthermore, the classic drug of choice for ventricular fibrillation in emergency setting, amiodarone, can worsen the dysrhythmia caused by digitalis, therefore, the second-choice drug lidocaine is more commonly used.

The entire plant is toxic (including the roots and seeds). Mortality is rare, but case reports do exist. Most plant exposures occur in children younger than six years and are usually unintentional and without associated significant toxicity. More serious toxicity occurs with intentional ingestion by adolescents and adults.

In some instances, people have confused foxglove with the relatively harmless comfrey (''Symphytum'') plant, which is sometimes brewed into a tea, with fatal consequences. Other fatal accidents involve children drinking the water in a vase containing digitalis plants. Drying does not reduce the toxicity of the plant. The plant is toxic to animals, including all classes of livestock and poultry, as well as felines and canines.

Trivia

According to 1981 speculation Vincent van Gogh's "Yellow Period" may have been influenced by digitalis, because it had been proposed as a therapy to control epilepsy around this time, and there are two paintings by the artist where the plant is present. Other studies immediately questioned this: there are a large number of other possible explanations for van Gogh's choice of palette, there is no evidence that van Gogh was ever given the drug or that his physician prescribed it, he was tested and had no xanthopsia, and in his many letters of the time he makes it clear that he simply liked using the colour yellow, but it has remained a popular concept.

References

External links

Molecule of the Month - Digitalis
*

{{Authority control

Plantaginaceae genera
Antiarrhythmic agents
Medicinal plants
Poisonous plants